Wuhan Historical Balance Sheet

300871 Stock

10.37 0.04 0.39%

Trend analysis of Wuhan Hvsen Biotechnology balance sheet accounts such as Total Current Liabilities of 943.1 M, Other Liabilities of 87.4 M or Net Tangible Assets of 1.7 B provides information on Wuhan Hvsen's total assets, liabilities, and equity, which is the actual value of Wuhan Hvsen Biotechnology to its prevalent stockholders. By breaking down trends over time using Wuhan Hvsen balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Wuhan Hvsen Inventory

143.97 Million

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Wuhan Hvsen Biotechnology. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

About Wuhan Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Wuhan Hvsen Biotechnology at a specified time, usually calculated after every quarter, six months, or one year. Wuhan Hvsen Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Wuhan Hvsen and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Wuhan currently owns. An asset can also be divided into two categories, current and non-current.

Wuhan Hvsen Balance Sheet Chart

At present, Wuhan Hvsen's Total Current Liabilities is projected to increase significantly based on the last few years of reporting. The current year's Other Liabilities is expected to grow to about 87.4 M, whereas Other Current Liabilities is forecasted to decline to about 4.2 M.

Other Current Liab Total Current Liabilities Other Liab Net Tangible Assets

Total Current Liabilities

Total Current Liabilities is an item on Wuhan Hvsen balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Wuhan Hvsen Biotechnology are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Net Tangible Assets

The total assets of a company minus any intangible assets such as patents, copyrights, and goodwill; it represents the physical assets of a company.

Most accounts from Wuhan Hvsen's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Wuhan Hvsen Biotechnology current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Wuhan Hvsen Biotechnology. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

	2022	2023	2024	2025 (projected)
Total Current Liabilities	804.9M	781.1M	898.2M	943.1M
Other Current Liabilities	61.5M	3.8M	4.4M	4.2M

Total Current Liabilities Other Current Liab

Wuhan Hvsen balance sheet Correlations

	Other Current Liab	Total Current Liabilities	Other Liab	Net Tangible Assets	Retained Earnings	Accounts Payable	Other Assets	Net Receivables	Inventory	Other Current Assets	Other Stockholder Equity	Deferred Long Term Liab	Total Current Assets	Common Stock	Property Plant Equipment	Total Assets	Total Stockholder Equity	Cash	Non Current Assets Total	Non Currrent Assets Other	Long Term Debt	Common Stock Shares Outstanding	Non Current Liabilities Total	Total Liab	Net Invested Capital	Non Current Liabilities Other
Other Current Liab		-0.07	-0.07	0.12	0.33	-0.06	0.23	0.14	0.13	0.48	0.27	0.1	0.3	0.15	-0.08	0.16	0.23	0.5	-0.09	0.43	0.1	0.11	-0.05	-0.06	0.17	0.61
Total Current Liabilities	-0.07		1.0	0.94	0.85	1.0	0.64	0.91	0.89	-0.12	0.53	-0.32	0.85	0.89	1.0	0.92	0.88	0.59	1.0	0.1	0.94	0.91	0.97	0.99	0.91	0.38
Other Liab	-0.07	1.0		0.94	0.85	1.0	0.66	0.91	0.89	-0.12	0.54	-0.34	0.85	0.88	0.99	0.91	0.88	0.6	0.99	0.12	0.93	0.91	0.97	0.99	0.91	0.39
Net Tangible Assets	0.12	0.94	0.94		0.93	0.95	0.79	0.92	0.92	0.07	0.62	-0.36	0.95	0.9	0.94	0.94	0.96	0.77	0.94	0.36	1.0	0.97	0.92	0.94	0.95	0.65
Retained Earnings	0.33	0.85	0.85	0.93		0.85	0.84	0.95	0.94	0.13	0.78	-0.37	0.97	0.91	0.83	0.94	0.97	0.8	0.83	0.47	0.92	0.93	0.82	0.83	0.95	0.68
Accounts Payable	-0.06	1.0	1.0	0.95	0.85		0.65	0.91	0.89	-0.13	0.52	-0.34	0.85	0.89	1.0	0.92	0.88	0.6	1.0	0.1	0.94	0.91	0.97	0.99	0.91	0.39
Other Assets	0.23	0.64	0.66	0.79	0.84	0.65		0.78	0.69	0.4	0.7	-0.41	0.8	0.64	0.6	0.73	0.82	0.54	0.61	0.81	0.81	0.82	0.52	0.58	0.74	0.75
Net Receivables	0.14	0.91	0.91	0.92	0.95	0.91	0.78		0.97	-0.04	0.65	-0.4	0.95	0.96	0.9	0.98	0.96	0.66	0.9	0.29	0.91	0.95	0.87	0.9	0.98	0.47
Inventory	0.13	0.89	0.89	0.92	0.94	0.89	0.69	0.97		-0.1	0.63	-0.38	0.96	0.99	0.89	0.99	0.97	0.77	0.89	0.22	0.91	0.95	0.9	0.9	0.99	0.49
Other Current Assets	0.48	-0.12	-0.12	0.07	0.13	-0.13	0.4	-0.04	-0.1		0.37	0.53	0.09	-0.13	-0.17	-0.06	0.08	0.08	-0.16	0.66	0.1	0.07	-0.23	-0.18	-0.04	0.54
Other Stockholder Equity	0.27	0.53	0.54	0.62	0.78	0.52	0.7	0.65	0.63	0.37		-0.01	0.65	0.54	0.5	0.59	0.63	0.54	0.5	0.51	0.59	0.62	0.48	0.5	0.6	0.49
Deferred Long Term Liab	0.1	-0.32	-0.34	-0.36	-0.37	-0.34	-0.41	-0.4	-0.38	0.53	-0.01		-0.39	-0.37	-0.31	-0.39	-0.4	-0.3	-0.32	-0.27	-0.35	-0.39	-0.3	-0.31	-0.39	-0.25
Total Current Assets	0.3	0.85	0.85	0.95	0.97	0.85	0.8	0.95	0.96	0.09	0.65	-0.39		0.95	0.84	0.97	1.0	0.84	0.84	0.42	0.94	0.97	0.84	0.85	0.98	0.69
Common Stock	0.15	0.89	0.88	0.9	0.91	0.89	0.64	0.96	0.99	-0.13	0.54	-0.37	0.95		0.9	0.99	0.95	0.74	0.89	0.15	0.89	0.94	0.91	0.9	0.99	0.45
Property Plant Equipment	-0.08	1.0	0.99	0.94	0.83	1.0	0.6	0.9	0.89	-0.17	0.5	-0.31	0.84	0.9		0.92	0.87	0.61	1.0	0.04	0.93	0.9	0.99	1.0	0.91	0.36
Total Assets	0.16	0.92	0.91	0.94	0.94	0.92	0.73	0.98	0.99	-0.06	0.59	-0.39	0.97	0.99	0.92		0.98	0.74	0.91	0.25	0.93	0.97	0.91	0.92	1.0	0.52
Total Stockholder Equity	0.23	0.88	0.88	0.96	0.97	0.88	0.82	0.96	0.97	0.08	0.63	-0.4	1.0	0.95	0.87	0.98		0.79	0.87	0.42	0.96	0.98	0.86	0.87	0.99	0.66
Cash	0.5	0.59	0.6	0.77	0.8	0.6	0.54	0.66	0.77	0.08	0.54	-0.3	0.84	0.74	0.61	0.74	0.79		0.61	0.35	0.74	0.72	0.68	0.64	0.77	0.78
Non Current Assets Total	-0.09	1.0	0.99	0.94	0.83	1.0	0.61	0.9	0.89	-0.16	0.5	-0.32	0.84	0.89	1.0	0.91	0.87	0.61		0.06	0.93	0.9	0.98	1.0	0.91	0.37
Non Currrent Assets Other	0.43	0.1	0.12	0.36	0.47	0.1	0.81	0.29	0.22	0.66	0.51	-0.27	0.42	0.15	0.04	0.25	0.42	0.35	0.06		0.38	0.39	-0.02	0.03	0.27	0.79
Long Term Debt	0.1	0.94	0.93	1.0	0.92	0.94	0.81	0.91	0.91	0.1	0.59	-0.35	0.94	0.89	0.93	0.93	0.96	0.74	0.93	0.38		0.97	0.9	0.92	0.94	0.66
Common Stock Shares Outstanding	0.11	0.91	0.91	0.97	0.93	0.91	0.82	0.95	0.95	0.07	0.62	-0.39	0.97	0.94	0.9	0.97	0.98	0.72	0.9	0.39	0.97		0.88	0.9	0.97	0.61
Non Current Liabilities Total	-0.05	0.97	0.97	0.92	0.82	0.97	0.52	0.87	0.9	-0.23	0.48	-0.3	0.84	0.91	0.99	0.91	0.86	0.68	0.98	-0.02	0.9	0.88		0.99	0.91	0.36
Total Liab	-0.06	0.99	0.99	0.94	0.83	0.99	0.58	0.9	0.9	-0.18	0.5	-0.31	0.85	0.9	1.0	0.92	0.87	0.64	1.0	0.03	0.92	0.9	0.99		0.91	0.37
Net Invested Capital	0.17	0.91	0.91	0.95	0.95	0.91	0.74	0.98	0.99	-0.04	0.6	-0.39	0.98	0.99	0.91	1.0	0.99	0.77	0.91	0.27	0.94	0.97	0.91	0.91		0.55
Non Current Liabilities Other	0.61	0.38	0.39	0.65	0.68	0.39	0.75	0.47	0.49	0.54	0.49	-0.25	0.69	0.45	0.36	0.52	0.66	0.78	0.37	0.79	0.66	0.61	0.36	0.37	0.55

Click cells to compare fundamentals

Wuhan Hvsen Account Relationship Matchups

Wuhan Hvsen balance sheet Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Other Current Liab	45.0M	57.9M	61.5M	3.8M	4.4M	4.2M
Total Current Liabilities	338.7M	503.3M	804.9M	781.1M	898.2M	943.1M
Other Liab	24.3M	28.0M	45.0M	72.4M	83.3M	87.4M
Net Tangible Assets	280.1M	1.3B	1.5B	1.4B	1.6B	1.7B
Retained Earnings	341.8M	429.3M	427.1M	341.9M	393.2M	271.4M
Accounts Payable	194.4M	311.3M	489.7M	472.5M	543.3M	570.5M
Other Assets	26.0M	67.0M	25.9M	32.7M	37.6M	26.7M
Net Receivables	201.7M	231.9M	338.0M	318.5M	366.3M	187.0M
Inventory	127.3M	231.6M	199.0M	228.7M	263.0M	144.0M
Other Current Assets	25.0M	9.4M	8.6M	5.3M	4.7M	9.1M
Total Current Assets	1.2B	1.6B	1.4B	1.3B	1.5B	863.0M
Property Plant Equipment	233.3M	412.3M	1.0B	1.5B	1.7B	1.8B
Total Assets	1.8B	2.7B	3.0B	3.0B	3.4B	1.9B
Total Stockholder Equity	1.4B	1.6B	1.5B	1.5B	1.7B	1.1B
Cash	345.3M	1.1B	424.0M	293.6M	337.7M	375.3M
Non Current Assets Total	575.1M	1.1B	1.6B	1.7B	2.0B	2.1B
Non Currrent Assets Other	56.7M	15.5M	7.5M	3.6M	4.2M	3.9M
Common Stock Shares Outstanding	165.8M	166.2M	166.1M	165.9M	190.8M	162.2M
Non Current Liabilities Total	34.4M	619.5M	642.8M	685.1M	787.9M	827.3M
Total Liab	373.1M	1.1B	1.4B	1.5B	1.7B	1.8B
Net Invested Capital	1.4B	2.3B	2.3B	2.4B	2.7B	1.5B
Non Current Liabilities Other	3.3M	2.9M	1.7M	845K	971.8K	1.7M
Net Working Capital	838.5M	1.1B	546.5M	484.9M	557.6M	510.8M
Intangible Assets	95.8M	110.1M	106.9M	104.2M	119.8M	101.2M
Short Long Term Debt	63M	100M	220.1M	240.3M	276.4M	290.2M
Capital Stock	110.5M	166.2M	166.1M	165.9M	190.8M	142.0M
Property Plant And Equipment Net	412.3M	1.0B	1.5B	1.6B	1.8B	1.0B
Property Plant And Equipment Gross	485.0M	1.1B	1.7B	1.8B	2.1B	1.2B

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

EBR	Centrais Electricas Brasileiras
HE	Hawaiian Electric Industries
VFC	VF Corporation

Other Information on Investing in Wuhan Stock

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Wuhan Historical Balance Sheet

Wuhan Hvsen Inventory

143.97 Million

About Wuhan Balance Sheet Analysis

Wuhan Hvsen Balance Sheet Chart

Total Current Liabilities

Net Tangible Assets

Wuhan Hvsen balance sheet Correlations

Wuhan Hvsen Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Wuhan Hvsen balance sheet Accounts

Also Currently Popular

Other Information on Investing in Wuhan Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Other Liab	+ 1.0	Total Current Liabilities
Accounts Payable	+ 1.0	Total Current Liabilities
Property Plant Equipment	+ 1.0	Total Current Liabilities
Non Current Assets Total	+ 1.0	Total Current Liabilities
Accounts Payable	+ 1.0	Other Liab
Long Term Debt	+ 1.0	Net Tangible Assets

Deferred Long Term Liab	- 0.41	Other Assets
Total Stockholder Equity	- 0.4	Deferred Long Term Liab
Deferred Long Term Liab	- 0.4	Net Receivables
Net Invested Capital	- 0.39	Deferred Long Term Liab
Common Stock Shares Outstanding	- 0.39	Deferred Long Term Liab
Total Assets	- 0.39	Deferred Long Term Liab